Your browser doesn't support javascript.
loading
Weight gain, body image and sexual function in young patients treated with contraceptive vaginal ring. A prospective pilot study.
Morotti, Elena; Casadio, Paolo; Guasina, Francesca; Battaglia, Bruno; Mattioli, Mara; Battaglia, Cesare.
Afiliación
  • Morotti E; a Department of Gynaecology and Pathophysiology of Human Reproduction , Alma Mater Studiorum-University of Bologna , Italy.
  • Casadio P; a Department of Gynaecology and Pathophysiology of Human Reproduction , Alma Mater Studiorum-University of Bologna , Italy.
  • Guasina F; a Department of Gynaecology and Pathophysiology of Human Reproduction , Alma Mater Studiorum-University of Bologna , Italy.
  • Battaglia B; a Department of Gynaecology and Pathophysiology of Human Reproduction , Alma Mater Studiorum-University of Bologna , Italy.
  • Mattioli M; a Department of Gynaecology and Pathophysiology of Human Reproduction , Alma Mater Studiorum-University of Bologna , Italy.
  • Battaglia C; a Department of Gynaecology and Pathophysiology of Human Reproduction , Alma Mater Studiorum-University of Bologna , Italy.
Gynecol Endocrinol ; 33(8): 660-664, 2017 Aug.
Article en En | MEDLINE | ID: mdl-28412867
ABSTRACT

INTRODUCTION:

Oral contraceptives could induce mood changes. As far as our knowledge, there are no studies in literature that have examined the role of vaginal contraception in self-perceived body image.

AIM:

To evaluate the effects of intravaginal contraception on weight gain and perceived body image in relation with the Beck's Depression Inventory questionnaire (BDI) and the McCoy Female Sexuality Questionnaire (MFSQ).

METHODS:

Twenty-one adult (18-35 years old) eumenorrheic (menstrual cycle of 25-35 days), lean (body mass index - BMI - of 19-25 kg/m2) women who were referred for hormonal contraception were administered the Stunkard Figure Rating Scale (FRS), BDI and MFSQ. Subjects were studied in basal condition and after 6 months of therapy with vaginal contraception (NuvaRing®; Organon-Schering-Plough Italia, Milan, Italy). MAIN OUTCOME

MEASURES:

BMI, FRS, MFSQ and BDI.

RESULTS:

After 6 months of therapy with NuvaRing®, both body weight (60.0 ± 8.3; p = 0.050) and BMI (22.1 ± 3.1; p = 0.028) slightly, but statistically, increased. FRS and BDI showed no differences after the vaginal contraception. Hormonal contraception was associated with a significant decrease in the two-factor Italian MFSQ score.

CONCLUSIONS:

Vaginal ring seems a good alternative to other hormonal contraceptive not significantly altering the female sexuality and not influencing the FRS and BDI.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Disfunciones Sexuales Fisiológicas / Desogestrel / Dispositivos Anticonceptivos Femeninos / Disfunciones Sexuales Psicológicas / Sobrepeso / Etinilestradiol / Trastorno Dismórfico Corporal Tipo de estudio: Observational_studies / Qualitative_research / Risk_factors_studies Límite: Adolescent / Adult / Female / Humans País/Región como asunto: Europa Idioma: En Revista: Gynecol Endocrinol Asunto de la revista: ENDOCRINOLOGIA / GINECOLOGIA Año: 2017 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Disfunciones Sexuales Fisiológicas / Desogestrel / Dispositivos Anticonceptivos Femeninos / Disfunciones Sexuales Psicológicas / Sobrepeso / Etinilestradiol / Trastorno Dismórfico Corporal Tipo de estudio: Observational_studies / Qualitative_research / Risk_factors_studies Límite: Adolescent / Adult / Female / Humans País/Región como asunto: Europa Idioma: En Revista: Gynecol Endocrinol Asunto de la revista: ENDOCRINOLOGIA / GINECOLOGIA Año: 2017 Tipo del documento: Article País de afiliación: Italia